The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Standard versus High-Dose CVVHDF for ICU-Related Acute Renal Failure
Open accessAbstract
The effect of dosage of continuous venovenous hemodiafiltration (CVVHDF) on survival in patients with acute renal failure (ARF) is unknown. In this study, 200 critically ill patients with ARF were randomly assigned to receive CVVHDF with prefilter replacement fluid at an effluent rate of either 35 ml/kg per h (high dosage) or 20 ml/kg per h (standard dosage). The primary study outcome, survival to the earlier of either intensive care unit discharge or 30 d, was 49% in the high-dosage arm and 56% in the standard-dosage arm (odds ratio 0.75; 95% confidence interval 0.43 to 1.32; P = 0.32). Among hospital survivors, 69% of those in the high-dosage arm recovered renal function compared with 80% of those in the standard-dosage arm (P = 0.29); therefore, a difference in patient survival or renal recovery was not detected between patients receiving high-dosage or standard-dosage CVVHDF. The mortality associated with acute renal failure (ARF) in the intensive care unit (ICU) has remained greater than 50% during the past three decades, despite improvements in renal replacement technology.1–5 Continuous renal replacement therapy (CRRT) has emerged as the predominant form of renal replacement therapy (RRT) in the ICU as a result of slow continuous fluid removal, steady acid-base and electrolyte correction, and beneficial effects on hemodynamic stability.6–8 There are no standardized protocols for prescribing or quantifying the adequacy of solute removal with CRRT.5 The available CRRT modalities differ according to whether solute clearance is accomplished primarily by diffusion, convection, or a combination of these techniques. Diffusion clears small molecular weight solutes efficiently across a concentration gradient but is relatively ineffective in clearing larger molecular weight solutes (>5000 Da). Convection removes water by mass transport across a pressure gradient, thereby removing both small and larger molecular weight solutes dissolved in the transported water. There is no consensus as to which one of these clearance techniques is best. The optimal dosage of CRRT in ICU patients with ARF has not been established. Although three randomized trials using differing CRRT modalities have evaluated the impact of dialysis dosage (defined by effluent rate) on patient survival in this population, they all were single-center studies with differing designs and compared different CRRT strategies.9–12 Continuous venovenous hemodiafiltration (CVVHDF), a CRRT technique that uses both convection and diffusion, is the only CRRT technique used at the University of Alabama at Birmingham (UAB). To determine the impact of CRRT dosage on patient outcomes, we conducted a prospective, randomized study comparing CVVHDF with prefilter replacement fluid using an effluent rate of 35 ml/kg per h versus an effluent rate of 20 ml/kg per h on patient survival in ICU patients with ARF. RESULTS A total of 254 ICU patients with ARF were screened. Two hundred patients were enrolled into the study, with 100 randomly assigned into each treatment arm. Reasons for exclusion are presented in Figure 1. Demographics and clinical characteristics are presented in Table 1. The two arms did not differ in their baseline characteristics, except for the percentage of patients mechanically ventilated, which was significantly higher in the high-dosage arm. Seventy-four patients were in the sepsis + oliguria stratum, 34 in the sepsis + nonoliguria stratum, 53 in the no sepsis + oliguria stratum, and 39 in the no sepsis + nonoliguria stratum. The proportion of patients with oliguria, sepsis, and preexisting chronic kidney disease (CKD; defined as premorbid serum creatinine >1.4 mg/dl) was similar for both treatment arms. CRRT parameters are described in Table 2. Accounting for the effect of predilution replacement fluid on solute clearance, the mean actual delivered dosage was 29 ml/kg per h in the high-dosage arm and 17 ml/kg per h in the standard-dosage arm (P < 0.001). More than 80% of the target effluent dosage was achieved in 74% of patients in the standard-dosage arm and 79% patients in the high-dosage arm (P = 0.45). Failure to achieve the target dosage was related to dialyzer thrombosis, catheter dysfunction, or ICU absence as a result of procedures. This did not differ between arms. Convective clearance composed 44% of the effluent volume in the high-dosage arm and 43% in the standard-dosage arm. Diffusive clearance composed 56 and 57% of the high- and standard-dosage arms, respectively. Total CRRT duration was 10 ± 9.8 d for the high-dosage arm and 9.7 ± 11.3 d for the standard-dosage arm (P = 0.88; Table 3). The primary study outcome, survival to the earlier of either ICU discharge or 30 d, was 49% in the high-dosage arm and 56% in the standard-dosage arm (odds ratio 0.75; 95% confidence interval 0.43 to 1.32; P = 0.32). Twenty-one percent of patients in the low-dosage arm and 22% in the high-dosage arm met the end point of survival to 30 d (P = 1.0). T
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Ronco, C., Bellomo, R., Homel, P., Brendolan, A., Dan, M., Piccinni, P., & La Greca, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02430-2 · Cited by 1,594
Brivet, F. G., Kleinknecht, D. J., Loirat, P., & Landais, P. J. M. (1996) · Critical Care Medicine · doi:10.1097/00003246-199602000-00003 · Cited by 879
Daily Hemodialysis and the Outcome of Acute Renal Failure
Schiffl, H., Lang, S. M., & Fischer, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010877 · Cited by 862
Bouman, C. S. C., Oudemans-van Straaten, H. M., Tijssen, J. G. P., Zandstra, D. F., & Kesecioglu, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200210000-00005 · Cited by 659
Liaño, F., Junco, E., Pascual, J., Madero, R., & Verde, E. (1998) · PubMed · Cited by 442
Saudan, P., Niederberger, M., De Seigneux, S., Romand, J., Pugin, J., Perneger, T., & Martin, P. Y. (2006) · Kidney International · doi:10.1038/sj.ki.5001705 · Cited by 440
Kellum, J. A., Bellomo, R., & Ronco, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10066-1 · Cited by 139
Bellomo, R., Mansfield, D. R., Rumble, S., et al. (1993) · Renal Failure · doi:10.3109/08860229309069409 · Cited by 55
Which albumin should we measure?
Becker, G. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09204.x · Cited by 42
Cited by
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802639 · Cited by 1,759
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902413 · Cited by 1,473
Continuous Renal Replacement Therapy
Tandukar, S., & Palevsky, P. M. (2019) · Chest · doi:10.1016/j.chest.2018.09.004 · Cited by 336
Schneider, A. G., Bellomo, R., Bagshaw, S. M., Glassford, N. J., Lo, S., Jun, M., Cass, A., & Gallagher, M. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2864-5 · Cited by 312
High-Molecular Weight Iron Dextran: A Wolf in Sheep's Clothing?
Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., Glaspy, J. A., & Henry, D. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030255 · Cited by 56
Metadata
- Authors
- Tolwani, A. J., Campbell, R. C., Stofan, B. S., Lai, K. R., Oster, R. A., & Wille, K. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-06
- Volume
- 19
- Issue
- 6
- Pages
- 1233-1238
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2100460458
- Cited by
- 295
- References
- 11
- FWCI
- 30.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Standard versus High-Dose CVVHDF for ICU-Related Acute Renal Failure. https://app.cochat.ai/papers/10.1681/asn.2007111173
- The paper
- Tolwani, A. J., Campbell, R. C., Stofan, B. S., Lai, K. R., Oster, R. A., & Wille, K. M. (2008). Standard versus High-Dose CVVHDF for ICU-Related Acute Renal Failure. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2007111173
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.